We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » European Pharma Predicted to Lose a Third of Its Global R&D With Proposed Legislation
European Pharma Predicted to Lose a Third of Its Global R&D With Proposed Legislation
The European Commission’s (EC) proposals to reduce a component of intellectual property protection for breakthrough medicines will hasten a trend which has seen Europe’s position as a global innovator deteriorate further in comparison to the U.S., China and Japan, according to a new study.